Home > Insider Trading > Filing (0001144204-16-141985)

Filing Details

Accession Number:: 0001144204-16-141985
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-12-30 18:51:10
Reporting Period:: 2016-09-12

Filing Date:: 2016-12-30
Accepted Time:: 2016-12-30 18:51:10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1274644	Ocera Therapeutics Inc.	OCRX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1202793	Michael Powell	C/O Sofinnova Ventures 3000 Sand Hill Road, Suite 4-250 Menlo Park CA 94025		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-09-12	18,374	$0.67	705,368	No	4	X	Indirect	See footnote
Common Stock	Acquisiton	2016-09-12	3,640	$0.67	139,752	No	4	X	Indirect	See footnote
Common Stock	Acquisiton	2016-09-12	250	$0.67	9,614	No	4	X	Indirect	See footnote
Common Stock	Disposition	2016-09-12	5,372	$2.29	699,996	No	4	S	Indirect	See footnote
Common Stock	Disposition	2016-09-12	1,066	$2.29	138,686	No	4	S	Indirect	See footnote
Common Stock	Disposition	2016-09-12	74	$2.29	9,540	No	4	S	Indirect	See footnote
Common Stock	Disposition	2016-10-31	699,996	$0.00	0	No	4	J	Indirect	See footnote
Common Stock	Disposition	2016-10-31	138,686	$0.00	0	No	4	J	Indirect	See footnote
Common Stock	Disposition	2016-10-31	9,540	$0.00	0	No	4	J	Indirect	See footnote
Common Stock	Acquisiton	2016-10-31	14,328	$0.00	14,328	No	4	J	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	X	Indirect	See footnote
No	4	X	Indirect	See footnote
No	4	X	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	J	Indirect	See footnote
No	4	J	Indirect	See footnote
No	4	J	Indirect	See footnote
No	4	J	Indirect	See footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock warrant (right to buy)	Disposition	2016-09-12	9,187	$0.00	9,187	$0.67
Common Stock	Stock warrant (right to buy)	Disposition	2016-09-12	9,187	$0.00	9,187	$0.67
Common Stock	Stock warrant (right to buy)	Disposition	2016-09-12	1,820	$0.00	1,820	$0.67
Common Stock	Stock warrant (right to buy)	Disposition	2016-09-12	1,820	$0.00	1,820	$0.67
Common Stock	Stock warrant (right to buy)	Disposition	2016-09-12	125	$0.00	125	$0.67
Common Stock	Stock warrant (right to buy)	Disposition	2016-09-12	125	$0.00	125	$0.67

Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2012-03-30	2019-03-30	No	4	X	Indirect
2012-10-01	2019-10-01	No	4	X	Indirect
2012-03-30	2019-03-30	No	4	X	Indirect
2012-10-01	2019-10-01	No	4	X	Indirect
2012-03-30	2012-03-30	No	4	X	Indirect
2012-10-01	2019-10-01	No	4	X	Indirect

Footnotes

Shares are held by Sofinnova Venture Partners VI, L.P. ("SV VI"). Sofinnova Management VI, L.L.C. ("SV LLC") is the general partner of SV VI and Michael F. Powell ("Powell"), a director of the Issuer, James I. Healy ("Healy"), Alain L. Azan ("Azan") and Eric P. Buatois ("Buatois"), the managing members of SV LLC, may be deemed to share voting and dispositive power over the shares held by such entities.
Shares are held by Sofinnova Venture Partners VI GmbH & Co. KG ("SV KG"). SV LLC is the managing limited partner of SV KG, and Healy, Powell, Azan and Buatois, the managing members of SV LLC, may be deemed to share voting and dispositive power over the shares held by such entities.
Shares are held by Sofinnova Venture Affiliates VI, L.P. ("SV A"). SV LLC is the general partner of SV A, and Healy, Powell, Azan and Buatois, the managing members of SV LLC, may be deemed to share voting and dispositive power over the shares held by such entities.
On September 12, 2016, the holder exercised warrants to purchase 18,374 shares of OCRX common stock for $0.67 a share. The holder paid the exercise price on a cashless basis, resulting in OCRX's withholding of 5,372 of the warrant shares to pay the exercise price and issuing to the holder the remaining 13,002 shares.
On September 12, 2016, the holder exercised warrants to purchase 3,640 shares of OCRX common stock for $0.67 a share. The holder paid the exercise price on a cashless basis, resulting in OCRX's withholding of 1,066 of the warrant shares to pay the exercise price and issuing to the holder the remaining 2,574 shares.
On September 12, 2016, the holder exercised warrants to purchase 250 shares of OCRX common stock for $0.67 a share. The holder paid the exercise price on a cashless basis, resulting in OCRX's withholding of 74 of the warrant shares to pay the exercise price and issuing to the holder the remaining 176 shares.
Represents a pro-rata in-kind distribution of Common Stock of the Issuer by SV VI without consideration to its partners.
Represents a pro-rata in-kind distribution of Common Stock of the Issuer by SV KG without consideration to its partners.
Represents a pro-rata in-kind distribution of Common Stock of the Issuer by SV A without consideration to its partners.
Shares acquired by SV LLC in connection with the distributions reported above.
Shares are held by SV LLC. SV LLC is the general partner of each of SV VI, SV KG, and SV A, and Healy, Powell, Azan and Buatois, the managing members of SV LLC, may be deemed to share voting and dispositive power over the shares held by such entities.